ArticleGeneral thoracic and cardiovascular surgery2026
Indications for segmentectomy in early-stage lung cancer based on solid volume analysis using three-dimensional computed tomography.
Article in General thoracic and cardiovascular surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application of the Ultraleap 3Di-Based Gesture-Controlled 3D Imaging Visualization System in Pulmonary Segmentectomy: A Single-Center Prospective Study.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAs indications for segmentectomy in small lung cancers expand, accurate preoperative computed tomography (CT) evaluation has become increasingly important. Irregularly shaped tumors require objective measurement techniques. This study assessed new segmentectomy criteria for early-stage non-small-cell lung cancer (NSCLC) using three-dimensional (3D) CT tumor volume.
methodsIn total, 200 segmentectomies and 691 lobectomies for clinical stage 0/IA NSCLC were retrospectively analyzed. Preoperative 3D-CT was performed to measure total tumor volume and solid component volume. To assess the predictive value of solid component volume and solid component ratio for recurrence and mortality, the receiver operating characteristic (ROC) curves for the segmentectomy and lobectomy groups were plotted individually. Based on the cut-off values derived from the ROC curves in the segmentectomy group, all cases were stratified into four categories ("volume high risk + ratio high risk", "volume high risk + ratio low risk", "volume low risk + ratio high risk", "volume low risk + ratio low risk"). Recurrence-free survival was analyzed using the log-rank test.
resultsThe cutoff values were 2063.4 mm
conclusionsThis exploratory analysis suggests that 3D-CT tumor quantification may aid in refining segmentectomy criteria; however, external validation is necessary before clinical application.
Indexed as
Identifiers
40779217What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.